Skin radiation-related angiosarcoma

Clinical trials for Skin radiation-related angiosarcoma explained in plain language.

Never miss a new study

Get alerted when new Skin radiation-related angiosarcoma trials appear

Sign up with your email to follow new studies for Skin radiation-related angiosarcoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for rare cancer: immune booster plus chemo shows promise

Disease control Ongoing

This phase II trial tests whether adding the immunotherapy drug nivolumab to the chemotherapy paclitaxel helps shrink tumors in people with angiosarcoma who haven't had taxane drugs before. For those who have already received taxanes, the trial tests a combination of nivolumab an…

Matched conditions: SKIN RADIATION-RELATED ANGIOSARCOMA

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC

Skin radiation-related angiosarcoma

Get alerted when new Skin radiation-related angiosarcoma trials appear

New hope for rare cancer: immune booster plus chemo shows promise